ResearcherVignan's Foundation for Science, Technology & ResearchActive in the last 2 years

Hemantha Mani Kumar Chakravarthi Chanda

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0008-3418-3374; OpenAlex author ID A5119747473. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 1

Papers, trials and grants by year

2026: 2 papers

Papers 2

In Silico identification of natural and synthetic inhibitors targeting KRAS mutants (G12D, G12V, and G12C) and wild-type in pancreatic cancer. Co-author DOI 10.1016/j.jmgm.2026.109504 ↗
Identification of Novel Tubulin Dimer Inhibitors for Pancreatic Cancer Using an Integrated Computational Approach. Co-author DOI 10.2174/0115734099490104260914114511 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Sudheer Kumar Katari · 2 shared papers, 2026 · strength 1.26
- Paper In Silico identification of natural and synthetic inhibitors targeting KRAS mutants (G12D, G12V, and G12C) and wild-typ… DOI 10.1016/j.jmgm.2026.109504 ↗
- Paper Identification of Novel Tubulin Dimer Inhibitors for Pancreatic Cancer Using an Integrated Computational Approach. DOI 10.2174/0115734099490104260914114511 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.